Protection by NMDA receptor antagonists against seizures induced by intracerebral administration of 4-aminopyridine

European Journal of Pharmacology

Volumn 305, Issue 1-3, 1996, Pages 87-93

  Morales Villagrán, Alberto ^a   Ureña Guerrero, Mónica E ^a   Tapia, Ricardo ^b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

4 aminopyridine; excitatory amino acid neurotransmission; NMDA receptor antagonist; seizure

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 4 AMINOPYRIDINE; DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CLONIC SEIZURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; GRAND MAL SEIZURE; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MASTICATION; MOTOR CORTEX; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; SALIVATION; SEIZURE; SPIKE; SPIKE WAVE; TONIC SEIZURE; TREMOR;

EID: 0343371821     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00157-4     Document Type: Article

References (30)

1. + channel blocker, Neurosci. Lett. 139, 34.
2. Belmar, E., G. García-Ugalde and R. Tapia, 1995, Motor alterations and neuronal damage induced by intracerebral administration of ruthenium red. Effect of NMDA receptor antagonists and other anticonvulsant drugs, Mol. Chem. Neuropathol. 26, 285.
3. Bever, C.T., 1994, The current status of studies of aminopyridines in patients with multiple sclerosis, Ann. Neurol. 36 Suppl., S118.
4. Bever, C.T., D. Young, P.A. Anderson, A. Krumholz, K. Conway, J. Leslie, N. Eddington, K.I. Plaisance, H.S. Panitch, S. Dhib-Jalbut, M.J. Fossler, J. Devane and K.P. Johnson, 1994, The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial, Neurology 44, 1054.
5. Collingridge, G.L., S.J. Kehl and H. McLennan, 1983, The antagonism of amino acid-induced excitations of rat hippocampal CA1 neurones in vitro, J. Physiol. (London) 334, 19.
6. Cramer, C.L., M.L. Stagnitto, M.A. Knowles and G.C. Palmer, 1994, Kainic acid and 4-aminopyridine seizure models in mice: evaluation of efficacy of antiepileptic agents and calcium antagonists, Life Sci. 54, PL271.
7. Dingledine, R., C.J. McBain and J.O. McNamara, 1990, Excitatory amino acid receptors in epilepsy, Trends Pharmacol. Sci. 11, 334.
8. Dolezal, V. and S. Tucek, 1983, The effect of 4-aminopyridine and tetrodotoxin on the release of acetylcholine from rat striatal slices, Naunyn-Schmied. Arch. Pharmacol. 323, 90.
9. Fariello, R.G., G.T. Golden, G.G. Smith and P.P. Reyes, 1989, Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist, Epilepsy Res. 3, 206.
10. Fragoso-Veloz, J. and R. Tapia, 1992, NMDA receptor antagonists protect against seizures and wet-dog shakes induced by 4-aminopyridine, Eur. J. Pharmacol. 221, 275.
11. Fragoso-Veloz, J., L. Massieu, R. Alvarado and R. Tapia, 1990, Seizures and wet-dog shakes induced by 4-aminopyridine, and their potentiation by nifedipine, Eur. J. Pharmacol. 178, 275.
12. + channel inhibitors, Eur. J. Pharmacol. 160, 173.
13. Gean, P.-W., 1990, The epileptiform activity induced by 4-aminopyridine in rat amygdala slices: antagonism by non-N-methyl-D-aspartate receptor antagonists, Brain Res. 530, 251.
14. Hayes, K.C., 1994, 4-Aminopyridine and spinal cord injury: a review, Restor. Neurol. Neurosci. 6, 259.
15. 3H]noradrenaline release from rat hippocampus, Eur. J. Pharmacol. 209, 87.
16. Lundh, H., 1978, Effects of 4-aminopyridine on neuromuscular transmission, Brain Res. 153, 307.
17. Meldrum, B.S., 1992, Excitatory amino acids in epilepsy and potential novel therapies, Epilepsy Res. 12, 189.
18. Morales-Villagrán, A. and R. Tapia, 1996, Preferential stimulation of glutamate release by 4-aminopyridine in rat striatum in vivo, Neurochem. Int. 28, 35.
19. Murray, N.M. and J. Newsom-Davis, 1981, Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission, Neurology 31, 265.
20. 3 hippocampal neurons by a variety of convulsants are not blocked by N-methyl-D-aspartate antagonists, Brain Res. 459, 265.
21. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates (Academic Press, Sydney).
22. Perreault, P. and M. Avoli, 1991, Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices, J. Neurophysiol. 65, 771.
23. Schafer Jr., E.W., R.B. Brunton and D.J. Cunningham, 1973, A summary of the acute toxicity of 4-aminopyridine to birds and mammals, Toxicol. Appl. Pharmacol. 26, 532.
24. Tapia, R. and J. Flores-Hernández, 1990, Circling behavior induced by intranigral administration of ruthenium red and 4-aminopyridine in the rat, Neuroscience 39, 657.
25. Tapia, R. and M. Sitges, 1982, Effect of 4-aminopyridine on transmitter release in synaptosomes, Brain Res. 250, 291.
26. Tapia, R., M. Sitges and E. Morales, 1985, Mechanism of the calcium-dependent stimulation of transmitter release by 4-aminopyridine in synaptosomes, Brain Res. 361, 373.
27. Thesleff, S., 1980, Aminopyridines and synaptic transmission, Neuroscience 5, 1413.
28. 2+ and glutamate release, J. Neurochem. 53, 1693.
29. Wesseling, H. and S. Agoston, 1984, Effects of 4-aminopyridine in elderly patients with Alzheimer's disease, New Engl. J. Med. 310, 988.
30. Yamaguchi, S. and M.A. Rogawski, 1992, Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res. 11, 9.